Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease

doi:10.3748/wjg.v23.i18.3356

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (25325)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

2149

WORD

330

HTML

18886

Figures (1-4)

145

Tables (1-3)

132

Sum=21642

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1145

Download

2029

Sum=3174

May 14, 2017 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (123)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastroenterol. May 14, 2017; 23(18): 3356-3366
Published online May 14, 2017. doi: 10.3748/wjg.v23.i18.3356

Table 3 Results of irritable bowel syndrome-symptom severity system response in subgroups of inflammatory bowel disease patients on low FODMAP

	Number	Week 0	Week 6	P value
Ulcerative colitis (UC)
UC	55 (71)	220 (190-300)	124 (40-198)	< 0.01
LFD	26 (47)	225 (187-260)	120 (36-170)	< 0.01
ND	29 (53)	220 (185-315)	141 (52-263)	< 0.01
0.37¹
Crohn’s disease (CD)
CD	23 (29)	245 (170-320)	170 (56-294)	< 0.01
LFD	11 (48)	210 (160-320)	58 (18-173)	0.02
ND	12 (52)	250 (172-382)	220 (57-357)	0.54
0.02¹
UC vs CD, P = 0.24¹
IBD-Remission by SCCAI/HBI
Remission	65 (83)	230 (175-305)	140 (39-212)	< 0.01
LFD	31 (48)	220 (170-250)	105 (26-167)	< 0.01
ND	34 (52)	242 (177-322)	175 (77-298)	< 0.01
< 0.01¹
IBD Mild-to-Moderate Activity by SCCAI/HBI
Activity	13 (17)	210 (200-350)	140 (103-252)	0.53
LFD	6 (46)	210 (194-391)	169 (105-332)	0.17
ND	7 (54)	260 (200-330)	140 (96-211)	0.06
0.53¹
Remission vs Activity, P < 0.01¹
FC-remission (≤ 100 μg/g UC, ≤ 200 μg/g CD), n = 53
Remission	53 (73)	220 (179-305)	113 (34-225)	< 0.01
LFD	25 (47)	220 (174-305)	60 (29-169)	< 0.01
ND	28 (53)	230 (180-307)	174 (66-298)	< 0.01
0.06¹
FC-activity (> 100 μg/g UC; > 200 μg/g CD), n = 20
Activity	20 (27)	250 (204-330)	160 (110-211)	< 0.01
LFD	11 (55)	210 (200-250)	157 (95-198)	0.04
ND	9 (45)	320 (230-360)	170 (103-291)	0.03
0.50¹
FC-Remission vs FC-Activity, P = 0.29¹
CRP-remission (< 10 mg/L), n = 75
Remission	75 (96)	230 (180-320)	140 (50-211)	< 0.01
LFD	35 (47)	210 (187-260)	114 (30-169)	< 0.01
ND	40 (53)	248 (180-320)	176 (78-288)	< 0.01
< 0.01¹
CD, prior surgery (bowel/ileo-coecal resections), n = 13/23 (57%)
LFD	11	225 (178-302)	10 (32-223)	< 0.01
ND	2	-	-

¹P: Mann-Whitney U test comparison of change in outcomes between treatment groups at 6-wk. All data are presented as median (IQR: Interquartile range), n (%) (- only 2 cases). P: Wilcoxon signed rank test, comparison of paired samples within each treatment group. IBS: Irritable bowel syndrome; SSS: Severity score system; IBD: Inflammatory bowel disease; LFD: Low FODMAP diet; ND: Normal Diet.

Citation: Pedersen N, Ankersen DV, Felding M, Wachmann H, Végh Z, Molzen L, Burisch J, Andersen JR, Munkholm P. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(18): 3356-3366
URL: https://www.wjgnet.com/1007-9327/full/v23/i18/3356.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i18.3356